Omega Therapeutics Inc. (OMGA)

NASDAQ: OMGA · Real-Time Price · USD

0.14

-0.00 (-1.82%)

At close: Feb 24, 2025, 3:59 PM

Omega Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	30.38M	45.85M	60.03M	68.44M	81.77M	105.54M	104.54M	70.61M	76.61M	90.86M	105.65M	186.48M	234.28M	122.41M	137.77M	22.95M	-2.27M
Short-Term Investments	n/a	n/a	n/a	4.99M	7.53M	7.44M	32.25M	54.06M	71.73M	82.81M	95.15M	38.84M	n/a	n/a	n/a	n/a	4.55M
Long-Term Investments	n/a	n/a	341K	341K	341K	341K	341K	341K	341K	341K	341K	341K	341K	341K	341K	n/a	n/a
Other Long-Term Assets	31K	51K	74K	94K	119K	150K	12.25M	13.12M	198K	146K	124K	101K	386K	308K	303K	598K	-2.27M
Receivables	486K	753K	1.21M	6.99M	1.43M	2.86M	1.26M	1.8M	1.24M	1.14M	1.58M	521K	367K	40K	248K	193K	n/a
Inventory	n/a	n/a	1.00	n/a	10.9M	-1.66M	-12.85M	41.15M	n/a	1.00	1.00	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.09M	9.1M	431K	431K	n/a	1.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.58M	n/a	n/a	n/a
Total Current Assets	38.95M	56.06M	70.89M	89.88M	101.9M	124.93M	136.79M	124.68M	161.04M	183.08M	206.46M	229.29M	238.76M	125.3M	139.78M	24M	2.27M
Property-Plant & Equipment	113.74M	112.11M	112.38M	114.05M	115.45M	103.6M	6.94M	7.86M	8.49M	9.48M	10.38M	3.6M	3.79M	4.1M	3.64M	3.48M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	113.77M	112.16M	112.79M	114.48M	115.91M	104.09M	19.53M	21.32M	9.03M	9.97M	10.84M	4.05M	4.51M	4.75M	4.29M	4.08M	-2.27M
Total Assets	152.73M	168.22M	183.68M	204.37M	217.81M	229.02M	156.31M	146M	170.06M	193.05M	217.3M	233.33M	243.27M	130.05M	144.07M	28.08M	n/a
Account Payables	1.43M	1.72M	1.58M	1.62M	2.4M	6.33M	3.68M	3.11M	2.57M	2.73M	2.05M	2.11M	911K	1.17M	3.35M	1.06M	n/a
Deferred Revenue	n/a	-8.64M	2M	n/a	7.52M	7.2M	n/a	n/a	n/a	n/a	n/a	n/a	8.71M	7.27M	4.51M	3.28M	n/a
Short-Term Debt	4M	15.83M	4M	15.3M	4M	19.52M	7.37M	4.86M	1.51M	1.66M	2.13M	n/a	4.5M	3M	1.5M	3M	n/a
Other Current Liabilities	4.83M	-5.68M	316K	-4.85M	n/a	-6.01M	4.07M	8.11M	5.36M	5.3M	6.2M	294K	7.13M	164K	165K	165K	n/a
Total Current Liabilities	24.17M	25.54M	24.68M	26.81M	26.82M	33.66M	18.1M	21.96M	14.7M	13.61M	13.55M	11.98M	14.31M	11.8M	9.73M	7.7M	n/a
Long-Term Debt	11.59M	12.91M	13.9M	14.88M	15.86M	11.62M	14.11M	16.6M	19.9M	19.89M	19.88M	19.87M	7.49M	8.81M	10.27M	8.73M	n/a
Other Long-Term Liabilities	4.8M	5.3M	2.41M	6.42M	340K	340K	340K	340K	340K	339K	340K	853K	1.14M	201.92M	201.95M	76.28M	n/a
Total Long-Term Liabilities	117.01M	116.42M	117.65M	119.54M	114.95M	99.45M	15.21M	18.06M	21.72M	22.06M	22.39M	20.72M	8.62M	210.73M	212.22M	85.01M	n/a
Total Liabilities	141.18M	141.96M	142.33M	146.35M	141.76M	133.1M	33.31M	40.03M	36.41M	35.66M	35.95M	32.7M	22.93M	222.53M	221.95M	92.71M	n/a
Total Debt	128.13M	126.95M	127.61M	128.43M	131.2M	118.62M	22.24M	22.58M	22.89M	23.38M	24.18M	19.87M	11.98M	11.81M	11.77M	11.73M	n/a
Common Stock	55K	55K	55K	55K	55K	55K	55K	48K	48K	48K	48K	48K	48K	5K	5K	5K	n/a
Retained Earnings	-387.51M	-371.07M	-354.76M	-334.63M	-314.42M	-292.17M	-262.49M	-237.21M	-206.38M	-180.58M	-154.67M	-134.5M	-113.65M	-95.12M	-79.71M	-66.22M	n/a
Comprehensive Income	n/a	n/a	-0.00	-14K	-86K	-171K	-228K	-479K	-917K	-1.01M	-859K	-62K	-243.27M	-227.3M	-200.59M	-75.22M	-35.92M
Shareholders Equity	11.54M	26.26M	41.35M	58.02M	76.04M	95.92M	123M	105.97M	133.65M	157.38M	181.35M	200.63M	220.34M	-92.48M	-77.88M	-64.63M	-9.21M
Total Investments	n/a	n/a	341K	5.33M	7.53M	7.44M	32.25M	54.06M	71.73M	82.81M	95.15M	38.84M	341K	341K	341K	n/a	4.55M